This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07461/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07461/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07461/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07461/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07461/identifier/chemspider/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07461
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB07461 n11:DB07461
dcterms:title
3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE
adms:identifier
n6:5287789 n9:99443932 n12:DB07461 n13:BIC n14:4450088
n3:IUPAC-Name
n4:271B4683-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4689-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4688-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4685-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4686-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4687-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4681-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4682-363D-11E5-9242-09173F13E4C5 n4:271B467F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4680-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B468F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4690-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B468A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B468B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B468D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B468C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B468E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4695-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4697-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4698-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4694-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4693-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4696-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4684-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4691-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4692-363D-11E5-9242-09173F13E4C5